Department : QA & QC -Executive 

Qualification: M.Sc ( Chemistry / Analytical / organic ) & B.Sc (Chemistry)

Experience:  1 to 4 years & 5 to 6 years 

Experience in API / Bulk Druge Industry

Department : Microbiology

Qualification: M.Sc (  Microbiology ) & B.Sc (Micro)

Experience:  1 to 4 years  & 5 to 6 years 

Department : AR & D

Qualification: M.Sc ( Organic / Analytical Chemistry)

Experience:  1 to 4 years  

Department : PR & D

Qualification: M.Sc ( Organic Chemistry)

Experience:  2 to 5 years  

Department : IPR - Executive 

Qualification: M.Sc ( Organic / Analytical Chemistry)

Experience:  2 to 3 years  of relevant Experience In IPR, IMP, Regulatory Organic Chemistry Documentation Candiadtes with a Diploma in intellectual Property Right will be preferred.

Department : QA & QC - jr. / Executive :

Qualification: M.Pharm( Pharmaceutical Analysis, Pharmaceutics)  B.Pharm / M.Sc

Experience: 1 to 5 years

Department : Production: Jr / Executive

Qualification: M.Pharm / M.Pharm

Experience:  2 to 5 years

Department : FBC & Drug Loading Operation 

Qualification: Intermediate / B.Sc 

Experience:  2 to 5 years of relevant experience

Date: 07 th & 08th January 2017

Venue: Hotel Aditya Inn, (UPstairs of jagruthi Restaurant), Main Road

Lankelapalem , visakhapatnam

Contact no: 9949933700

VASUDHA PHARMA CHEM LIMITED is incorporated as a public limited company under the Companies Act, 1956 at Hyderabad in the state of Andhra Pradesh, India during the year 1994 - 95. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates for catering to the domestic as well as international market.

The company recognized the vital role of R & D for becoming successful in the generic market. Initially, the focus was on development of cost effective processes for several intermediates related to piperidone & piperidine derivatives. By 2003 -04, the company gained world class expertise and became the largest manufacturer of piperidone & piperidine derivatives in the world. Subsequently, the company forward integrated from intermediates of piperidone & piperidine derivatives to APIs and later on diversified into large product portfolio of about 27 APIs spreading across several therapeutic areas.